
- WORLD EDITIONAustraliaNorth AmericaWorld
September 10, 2023
Lithium Universe Limited (“Lithium Universe”, or the “Company”) is pleased to announce the appointment of world-renowned lithium expert Dr Jingyuan Liu as Non-Executive Director to the Board. This is a key appointment that strengthens the existing lithium experience and technical capability of the LU7 Board.
Highlights
- Key appointment of Dr Jingyuan Liu as Non-Executive Director
- Pre-eminent technical expert in the lithium industry
- Former GM Development and Technologies with Galaxy Resources Limited
- Intimate construction and operating experience of Jiangsu Lithium Carbonate Plant
- Tasked with considering the Québec Lithium Processing Hub strategy in James Bay
Dr Jingyuan Liu is widely regarded as a leading technical expert in the lithium industry. He previously held the position of General Manager of Development and Technologies at Galaxy Resources Limited, where he was responsible for overseeing the construction and commissioning of the world-renowned Jiangsu Lithium Carbonate plant, now owned by Tianqi Lithium Corp. Jingyuan also played a key role in designing the flow sheet for the Sal de Vida brine project in Argentina. Following his work with Galaxy, he has acted as a special adviser to various lithium carbonate and lithium hydroxide projects globally, including the Lithium Hydroxide Plant operated by Tianqi in Kwinana, Western Australia.
Jingyuan has over 30 years of experience in project management, process, and equipment design for minerals processing and in the chemicals, non-ferrous metals, iron & steel, and energy industries, both in Australia and internationally. He was awarded a PhD in chemical engineering from the University of Newcastle, Australia. He has worked in senior chemical engineering roles with leading companies such as Hatch Engineering and Metso Minerals in Australia and Malaysia.
Dr Liu is currently the Chief Technology Officer (CTO) for Altech Batteries Limited (ASX: ATC) developing high- capacity silicon anode lithium-ion batteries as well as sodium chloride solid-state batteries.
In response to his appointment, Dr. Liu expressed his excitement about joining the team that is tasked with considering the Company’s Québec Lithium Processing Hub (QLPH) strategy in James Bay, Québec, Canada. He explained that the QLPH is envisioned to encompass a versatile, standalone concentrator known as the QLPH Concentrator, boasting a processing capacity of 1 million metric tons per annum. This facility will serve as a vital source for a lithium carbonate refinery, the QLPH Lithium Carbonate Refinery, with the capability to produce 16,000 tons per annum of battery-grade lithium carbonate.
Dr. Liu shared the Company’s vision of becoming the preferred downstream solution for small to mid-sized lithium mining operations in Canada, with an intended target market encompassing Canada, the United States, and Europe for their battery-grade lithium carbonate. He elaborated on their strategic choice to focus on lithium carbonate over lithium hydroxide, driven by the anticipated growth in demand for carbonate attributed to the increased adoption of Lithium Iron Phosphate (LFP) batteries in the electric vehicle (EV) industry. He cited Tesla's shift to LFP lithium-ion batteries as a notable example, owing to their enhanced safety features and cost- effectiveness. Currently, the split between carbonate and hydroxide production stands close to a 50/50 ratio. In conclusion, Dr. Liu underscored his well-established track record, citing his extensive experience with the Jiangsu Lithium Carbonate plant, a globally renowned benchmark for producing high-quality battery-grade lithium carbonate.
Commenting on the critical strategic appointment, Chairman, Mr. Iggy Tan said “Dr Liu is well known in the lithium industry as the “go to expert” in lithium carbonate or lithium hydroxide technology. Dr Jingyuan Liu's appointment as Non-Executive Director to the Board of Directors of Lithium Universe Limited is a significant move that further enhances the Board's expertise in the lithium industry, with Jingyuan having served as a special adviser for numerous lithium projects globally. With his expertise in operating the Jiangsu Lithium Carbonate Plant and being my right-hand man during our time at Galaxy, LU7 is fortunate to have such a critical lithium professional on the Board.” He said.
Click here for the full ASX Release
This article includes content from Lithium Universe Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
LU7:AU
The Conversation (0)
03 September
Macquarie Electro Jet Silver Extraction Recovery
Lithium Universe (LU7:AU) has announced Macquarie Electro Jet Silver Extraction RecoveryDownload the PDF here. Keep Reading...
12 August
Acquisition of Silver Extraction Technology
Lithium Universe (LU7:AU) has announced Acquisition of Silver Extraction TechnologyDownload the PDF here. Keep Reading...
30 July
Quarterly Activities/Appendix 5B Cash Flow Report
Lithium Universe (LU7:AU) has announced Quarterly Activities/Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
30 July
Lithium Universe Ltd Quarterly Activities Report
Melbourne, Australia (ABN Newswire) - During the June quarter, Lithium Universe Ltd (ASX:LU7,OTC:LUVSF) (FRA:KU00) (OTCMKTS:LUVSF) announced the acquisition of the global rights to commercially exploit a patented photovoltaic solar panel recycling technology known as "Microwave Joule Heating... Keep Reading...
17 July
Completion of PV Solar Cell Recycling Acquisition
Lithium Universe (LU7:AU) has announced Completion of PV Solar Cell Recycling AcquisitionDownload the PDF here. Keep Reading...
17 October
Successful A$4.5M Placement to Accelerate Battery, REE and Solar Panel Recycling Growth
Livium Ltd (ASX: LIT) (“Livium” or the “Company”) is pleased to announce it has received firm commitments from new and existing, institutional and sophisticated investors to raise $4.5m (“Placement”) before costs. HighlightsFirm commitments of A$4.5m received from institutional and sophisticated... Keep Reading...
15 October
7 Biggest Lithium-mining Companies in 2025
For a long time, most of the world's lithium was produced by an oligopoly of US-listed producers. However, the sector has transformed significantly in recent years.Interested investors should cast a wider net to look at global companies — in particular those listed in Australia and China, as... Keep Reading...
15 October
Livium Ltd (ASX: LIT) – Trading Halt
Trading in the securities of Livium Ltd (‘LIT’) will be halted at the request of LIT, pending the release of an announcement by LIT. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: the commencement of normal trading on Friday, 17 October 2025; orthe... Keep Reading...
14 October
GM Takes US$1.6 Billion Hit on EV Realignment as US Policy Shift Clouds Market Outlook
General Motors (NYSE:GM) will take a US$1.6 billion charge tied to its electric vehicle (EV) production realignment as the federal government rolls back clean energy incentives and emissions standards.In a regulatory filing on Tuesday (October 14), GM said the charges include a US$1.2 billion... Keep Reading...
13 October
EUR Sells a Further 3.85 Million CRML Shares for US$50M (A$76M) to a US Institutional Investor
European Lithium Ltd (ASX: EUR, FRA:PF8, OTC: EULIF) (European Lithium or the Company) is pleased to announce that Critical Metals Corp. (Nasdaq: CRML) in an off-market transaction has sold a further 3.85 million CRML shares to a single US institutional investor at US$13 per share (a 12%... Keep Reading...
12 October
Successful A$4.5m Two Tranche Placement
Green Technology Metals (GT1:AU) has announced Successful A$4.5m Two Tranche PlacementDownload the PDF here. Keep Reading...
Latest News
Latest Press Releases
CSE Bulletin: MOC Eligibility Update
17 October
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00